CAN
GSK icon

Cetera Advisor Networks’s GSK GSK Stock Holding History

Cetera Advisor Networks’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$7.56M Buy
176,443
+656
+0.4% +$27.1K 0.04% 469
2023
Q4 		$6.51M Buy
175,787
+9,366
+6% +$336K 0.04% 464
2023
Q3 		$6.03M Buy
166,421
+83,556
+101% +$2.97M 0.04% 448
2023
Q2 		$2.95M Buy
82,865
+626
+0.8% +$22.5K 0.02% 716
2023
Q1 		$2.93M Buy
82,239
+2,811
+4% +$98.3K 0.02% 698
2022
Q4 		$2.79M Buy
79,428
+15,377
+24% +$512K 0.02% 676
2022
Q3 		$1.89M Sell
64,051
-2,821
-4% -$107K 0.02% 619
2022
Q2 		$3.64M Buy
66,872
+15,833
+31% +$874K 0.05% 390
2022
Q1 		$2.78M Buy
51,039
+5,325
+12% +$289K 0.03% 508
2021
Q4 		$2.52M Buy
45,714
+4,589
+11% +$239K 0.03% 519
2021
Q3 		$1.96M Buy
41,125
+8,331
+25% +$418K 0.03% 559
2021
Q2 		$1.63M Buy
32,794
+9,301
+40% +$447K 0.02% 611
2021
Q1 		$1.05M Buy
23,493
+6,507
+38% +$295K 0.02% 571
2020
Q4 		$781K Buy
16,986
+5,150
+44% +$237K 0.02% 624
2020
Q3 		$557K Sell
11,836
-3,573
-23% -$179K 0.01% 675
2020
Q2 		$786K Buy
15,409
+1,466
+11% +$75.2K 0.02% 536
2020
Q1 		$660K Sell
13,943
-821
-6% -$43.8K 0.02% 520
2019
Q4 		$864K Buy
14,764
+1,186
+9% +$66K 0.02% 543
2019
Q3 		$727K Sell
13,578
-373
-3% -$19.2K 0.02% 564
2019
Q2 		$698K Sell
13,951
-575
-4% -$28.9K 0.02% 573
2019
Q1 		$756K Buy
14,526
+1,516
+12% +$75.8K 0.02% 528
2018
Q4 		$622K Sell
13,010
-400
-3% -$19.7K 0.02% 512
2018
Q3 		$672K Buy
13,410
+910
+7% +$46.2K 0.02% 538
2018
Q2 		$627K Sell
12,500
-2,315
-16% -$117K 0.03% 411
2018
Q1 		$727K Sell
14,815
-4,988
-25% -$232K 0.03% 399
2017
Q4 		$885K Sell
19,803
-1,902
-9% -$87.9K 0.04% 400
2017
Q3 		$1.09M Sell
21,705
-1,432
-6% -$72.7K 0.05% 312
2017
Q2 		$1.24M Sell
23,137
-2,904
-11% -$155K 0.06% 276
2017
Q1 		$1.36M Buy
26,041
+246
+1% +$12.5K 0.07% 253
2016
Q4 		$1.26M Sell
25,795
-12,236
-32% -$604K 0.07% 254
2016
Q3 		$2.05M Buy
38,031
+12,009
+46% +$658K 0.08% 228
2016
Q2 		$1.41M Buy
26,022
+5,706
+28% +$301K 0.08% 233
2016
Q1 		$1.03M Sell
20,316
-1,781
-8% -$88.7K 0.06% 270
2015
Q4 		$1.11M Buy
22,097
+1,903
+9% +$97K 0.07% 257
2015
Q3 		$981K Sell
20,194
-2,685
-12% -$140K 0.07% 264
2015
Q2 		$1.33M Hold
22,879
– – 0.09% 236
2015
Q1 		$1.33M Buy
22,879
+4,319
+23% +$248K 0.09% 236
2014
Q4 		$993K Buy
18,560
+6,569
+55% +$368K 0.07% 276
2014
Q3 		$689K Buy
11,991
+321
+3% +$19.7K 0.05% 364
2014
Q2 		$780K Buy
11,670
+1,040
+10% +$70.4K 0.05% 354
2014
Q1 		$710K Buy
10,630
+2,442
+30% +$165K 0.05% 353
2013
Q4 		$547K Buy
8,188
+580
+8% +$37.6K 0.04% 384
2013
Q3 		$481K Buy
7,608
+90
+1% +$5.79K 0.04% 361
2013
Q2 		$465K Buy
+7,518
New +$477K 0.05% 331

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Advisor Networks's GSK Position: Q1 2024 in Review

Cetera Advisor Networks increased its GSK (GSK) stake by 0.37% in Q1 2024, buying an estimated $27.1K and bringing the position to 176,443 shares worth $7.56M. The position accounts for 0.04% of the portfolio, ranked #469.

Cetera Advisor Networks first reported a position in GSK in Q2 2013 and has held it in 44 quarters since. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Cetera Advisor Networks held 176,443 shares of GSK worth $7.56M as of Q1 2024.
  • Cetera Advisor Networks bought 656 GSK shares in Q1 2024, an estimated $27.1K.
  • GSK made up 0.04% of Cetera Advisor Networks's portfolio in Q1 2024, its #469 holding.
  • Cetera Advisor Networks first reported a position in GSK in Q2 2013 and has held it in 44 quarters since.
  • 911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.